News | Pfizer | Pfizer

Home
News

Fake Drugs 101: Facts on Illegal, Counterfeit Drugs

Get the basics on fake drugs. What exactly are counterfeit drugs? How big is the counterfeit drug problem? And who's at risk?

Your Health

8 Common STDs: What You Need to Know

Knowing what to look out for can help you address STDs before they cause long-term harm to the individual or spread within a community. Here’s what you need to know about eight common STDs.

Science

How a Coronavirus Protease Inhibitor Works to Fight COVID-19

SARS-CoV-2, the virus that causes COVID-19, was sometimes called the “novel coronavirus” in the early days of the pandemic.

Search More Stories

Behind the Science Features

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

Go Behind the Science

Media Resources

This information is intended for media professionals. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Pipeline Snapshot as of May 3, 2022

00Phase 1
00Phase 2
00Phase 3
00Registration
00Total

Download Complete Pipeline PDF

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site

Our Careers

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Explore Our Careers

To Our Investors

Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.

To Our Investors

Stay Informed. Knowledge is Power.

Fake Drugs 101: Facts on Illegal, Counterfeit Drugs

8 Common STDs: What You Need to Know

How a Coronavirus Protease Inhibitor Works to Fight COVID-19

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

May 2022

Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis

Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose

Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age

Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission

Pfizer to Acquire Biohaven Pharmaceuticals

Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis

Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022

Pfizer Reports First-Quarter 2022 Results

April 2022

Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID™ for Post-Exposure Prophylactic Use

Pfizer Announces 2022 Shareholder Meeting Preliminary Results

Pfizer Declares Second-Quarter 2022 Dividend

Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for Ambulatory Patients with Duchenne Muscular Dystrophy

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.

Why Invest

Financial Reports

Events and Presentations

Stock Information

Investor News

Shareholder Services